TGTX logo

TG Therapeutics, Inc. (TGTX) Free cash flow

annual FCF:

-$40.56M-$9.15M(-29.12%)
December 31, 2024

Summary

  • As of today (July 16, 2025), TGTX annual free cash flow is -$40.56 million, with the most recent change of -$9.15 million (-29.12%) on December 31, 2024.
  • During the last 3 years, TGTX annual FCF has risen by +$255.47 million (+86.30%).
  • TGTX annual FCF is now -46738.34% below its all-time high of -$86.60 thousand, reached on December 31, 2011.

Performance

TGTX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

quarterly FCF:

-$28.74M-$3.08M(-11.99%)
March 1, 2025

Summary

  • As of today (July 16, 2025), TGTX quarterly free cash flow is -$28.74 million, with the most recent change of -$3.08 million (-11.99%) on March 1, 2025.
  • Over the past year, TGTX quarterly FCF has dropped by -$20.53 million (-250.19%).
  • TGTX quarterly FCF is now -134.34% below its all-time high of $83.70 million, reached on September 30, 2023.

Performance

TGTX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

TTM FCF:

-$61.09M-$20.53M(-50.62%)
March 1, 2025

Summary

  • As of today (July 16, 2025), TGTX TTM free cash flow is -$61.09 million, with the most recent change of -$20.53 million (-50.62%) on March 1, 2025.
  • Over the past year, TGTX TTM FCF has dropped by -$81.38 million (-401.23%).
  • TGTX TTM FCF is now -190.08% below its all-time high of $67.82 million, reached on June 30, 2024.

Performance

TGTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

TGTX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%-250.2%-401.2%
3 y3 years+86.3%+58.2%+78.4%
5 y5 years+69.5%+53.8%+64.0%

TGTX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.1%+86.3%-134.3%+52.0%-190.1%+77.5%
5 y5-year-29.1%+86.3%-134.3%+67.0%-190.1%+79.4%
alltimeall time<-9999.0%+86.3%-134.3%+67.0%-190.1%+79.4%

TGTX Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$28.74M(+12.0%)
-$61.09M(+50.6%)
Dec 2024
-$40.56M(+29.1%)
-$25.66M(+109.8%)
-$40.56M(+44.3%)
Sep 2024
-
-$12.23M(-320.9%)
-$28.11M(-141.4%)
Jun 2024
-
$5.54M(-167.5%)
$67.82M(+234.4%)
Mar 2024
-
-$8.21M(-37.9%)
$20.28M(-164.6%)
Dec 2023
-$31.41M(-82.2%)
-$13.21M(-115.8%)
-$31.41M(-25.3%)
Sep 2023
-
$83.70M(-299.3%)
-$42.08M(-73.7%)
Jun 2023
-
-$42.01M(-29.9%)
-$160.28M(-4.2%)
Mar 2023
-
-$59.90M(+150.9%)
-$167.39M(-5.0%)
Dec 2022
-$176.18M(-40.5%)
-$23.87M(-30.8%)
-$176.18M(-26.4%)
Sep 2022
-
-$34.50M(-29.8%)
-$239.30M(-12.0%)
Jun 2022
-
-$49.12M(-28.5%)
-$272.08M(-4.0%)
Mar 2022
-
-$68.70M(-21.0%)
-$283.31M(-4.3%)
Dec 2021
-$296.04M(+37.8%)
-$86.99M(+29.3%)
-$296.04M(+13.3%)
Sep 2021
-
-$67.28M(+11.5%)
-$261.23M(+4.3%)
Jun 2021
-
-$60.34M(-25.9%)
-$250.57M(+7.0%)
Mar 2021
-
-$81.42M(+56.0%)
-$234.10M(+9.0%)
Dec 2020
-$214.86M(+61.6%)
-$52.18M(-7.8%)
-$214.86M(+11.3%)
Sep 2020
-
-$56.62M(+29.0%)
-$193.11M(+13.8%)
Jun 2020
-
-$43.88M(-29.4%)
-$169.76M(+4.9%)
Mar 2020
-
-$62.18M(+104.4%)
-$161.75M(+21.7%)
Dec 2019
-$132.94M(+3.0%)
-$30.43M(-8.5%)
-$132.94M(-2.4%)
Sep 2019
-
-$33.27M(-7.3%)
-$136.21M(+0.2%)
Jun 2019
-
-$35.88M(+7.5%)
-$135.97M(+1.2%)
Mar 2019
-
-$33.37M(-1.0%)
-$134.31M(+4.1%)
Dec 2018
-$129.01M(+37.6%)
-$33.70M(+2.0%)
-$129.01M(+10.1%)
Sep 2018
-
-$33.03M(-3.5%)
-$117.17M(+9.6%)
Jun 2018
-
-$34.22M(+21.9%)
-$106.91M(+7.4%)
Mar 2018
-
-$28.07M(+28.4%)
-$99.53M(+6.1%)
Dec 2017
-$93.76M(+51.4%)
-$21.86M(-4.0%)
-$93.76M(+5.4%)
Sep 2017
-
-$22.77M(-15.1%)
-$88.95M(+9.5%)
Jun 2017
-
-$26.83M(+20.3%)
-$81.23M(+20.7%)
Mar 2017
-
-$22.30M(+30.9%)
-$67.28M(+8.6%)
Dec 2016
-$61.93M(+38.4%)
-$17.04M(+13.2%)
-$61.93M(+7.2%)
Sep 2016
-
-$15.06M(+16.9%)
-$57.77M(+8.2%)
Jun 2016
-
-$12.88M(-24.0%)
-$53.42M(+1.2%)
Mar 2016
-
-$16.96M(+31.6%)
-$52.80M(+18.0%)
Dec 2015
-$44.73M(+27.5%)
-$12.88M(+20.4%)
-$44.73M(-4.8%)
Sep 2015
-
-$10.70M(-12.8%)
-$46.97M(+6.0%)
Jun 2015
-
-$12.26M(+37.9%)
-$44.32M(+24.4%)
Mar 2015
-
-$8.89M(-41.2%)
-$35.64M(+1.6%)
Dec 2014
-$35.08M(+226.5%)
-$15.12M(+87.8%)
-$35.08M(+41.5%)
Sep 2014
-
-$8.05M(+125.4%)
-$24.78M(+38.6%)
Jun 2014
-
-$3.57M(-57.1%)
-$17.89M(+6.0%)
Mar 2014
-
-$8.33M(+72.6%)
-$16.87M(+57.0%)
Dec 2013
-$10.74M(+107.1%)
-$4.83M(+317.7%)
-$10.74M(+59.1%)
Sep 2013
-
-$1.16M(-54.8%)
-$6.75M(-21.4%)
Jun 2013
-
-$2.56M(+16.0%)
-$8.59M(+31.5%)
Mar 2013
-
-$2.20M(+164.6%)
-$6.53M(+25.9%)
Dec 2012
-$5.19M(+5892.4%)
-$833.30K(-72.2%)
-$5.19M(+17.6%)
Sep 2012
-
-$2.99M(+497.2%)
-$4.41M(+204.4%)
Jun 2012
-
-$501.20K(-41.8%)
-$1.45M(<-9900.0%)
Mar 2012
-
-$861.60K(+1425.0%)
$0.00(-100.0%)
Dec 2011
-$86.60K(-95.6%)
-$56.50K(+87.7%)
-$86.60K(-84.9%)
Sep 2011
-
-$30.10K(-103.2%)
-$571.80K(-40.1%)
Jun 2011
-
$948.20K(-200.0%)
-$954.40K(-58.8%)
Mar 2011
-
-$948.20K(+75.0%)
-$2.32M(+17.4%)
DateAnnualQuarterlyTTM
Dec 2010
-$1.97M(+87.9%)
-$541.70K(+31.3%)
-$1.97M(+12.2%)
Sep 2010
-
-$412.70K(-0.2%)
-$1.76M(+18.3%)
Jun 2010
-
-$413.70K(-31.6%)
-$1.49M(+47.4%)
Mar 2010
-
-$604.80K(+84.9%)
-$1.01M(-3.9%)
Dec 2009
-$1.05M(-76.4%)
-$327.10K(+132.2%)
-$1.05M(-36.1%)
Sep 2009
-
-$140.90K(-319.8%)
-$1.64M(-22.6%)
Jun 2009
-
$64.10K(-109.9%)
-$2.12M(-41.7%)
Mar 2009
-
-$645.80K(-29.8%)
-$3.64M(-18.3%)
Dec 2008
-$4.45M(-56.5%)
-$919.80K(+48.3%)
-$4.45M(-9.4%)
Sep 2008
-
-$620.30K(-57.3%)
-$4.92M(-30.3%)
Jun 2008
-
-$1.45M(-0.7%)
-$7.05M(-25.9%)
Mar 2008
-
-$1.46M(+5.7%)
-$9.51M(-7.1%)
Dec 2007
-$10.24M(+31.5%)
-$1.38M(-49.8%)
-$10.24M(-0.1%)
Sep 2007
-
-$2.76M(-29.6%)
-$10.25M(+6.5%)
Jun 2007
-
-$3.91M(+78.9%)
-$9.62M(+17.5%)
Mar 2007
-
-$2.19M(+57.4%)
-$8.19M(+5.2%)
Dec 2006
-$7.79M(+23.9%)
-$1.39M(-34.8%)
-$7.79M(-8.1%)
Sep 2006
-
-$2.13M(-14.1%)
-$8.48M(+9.1%)
Jun 2006
-
-$2.48M(+39.1%)
-$7.77M(+14.8%)
Mar 2006
-
-$1.78M(-14.2%)
-$6.77M(+7.7%)
Dec 2005
-$6.28M(+7.8%)
-$2.08M(+45.8%)
-$6.28M(+1.2%)
Sep 2005
-
-$1.43M(-3.7%)
-$6.21M(-1.5%)
Jun 2005
-
-$1.48M(+14.1%)
-$6.30M(+8.4%)
Mar 2005
-
-$1.30M(-35.1%)
-$5.81M(-0.3%)
Dec 2004
-$5.83M(+68.6%)
-$2.00M(+31.8%)
-$5.83M(+5.2%)
Sep 2004
-
-$1.52M(+53.0%)
-$5.54M(+21.9%)
Jun 2004
-
-$993.00K(-24.5%)
-$4.55M(+7.7%)
Mar 2004
-
-$1.31M(-23.4%)
-$4.22M(+22.1%)
Dec 2003
-$3.46M(+351.6%)
-$1.72M(+226.9%)
-$3.46M(+160.0%)
Sep 2003
-
-$524.70K(-21.5%)
-$1.33M(-10.1%)
Jun 2003
-
-$668.70K(+21.7%)
-$1.48M(+112.8%)
Mar 2003
-
-$549.40K(-233.1%)
-$695.40K(-9.2%)
Dec 2002
-$765.70K(-83.3%)
$412.80K(-161.2%)
-$765.70K(-61.1%)
Sep 2002
-
-$674.50K(-683.0%)
-$1.97M(+4.5%)
Jun 2002
-
$115.70K(-118.7%)
-$1.88M(-31.3%)
Mar 2002
-
-$619.70K(-21.4%)
-$2.74M(-40.3%)
Dec 2001
-$4.58M(+246.0%)
-$788.80K(+33.8%)
-$4.58M(+97.6%)
Sep 2001
-
-$589.40K(-20.4%)
-$2.32M(-5.4%)
Jun 2001
-
-$740.00K(-70.0%)
-$2.45M(-27.1%)
Mar 2001
-
-$2.46M(-267.1%)
-$3.36M(+153.6%)
Dec 2000
-$1.32M(-44.8%)
$1.48M(-304.6%)
-$1.32M(-55.8%)
Sep 2000
-
-$720.90K(-56.3%)
-$3.00M(+12.0%)
Jun 2000
-
-$1.65M(+283.6%)
-$2.68M(+38.8%)
Mar 2000
-
-$429.80K(+114.9%)
-$1.93M(-16.1%)
Dec 1999
-$2.40M(-14.3%)
-$200.00K(-50.0%)
-$2.30M(-30.3%)
Sep 1999
-
-$400.00K(-55.6%)
-$3.30M(-21.4%)
Jun 1999
-
-$900.00K(+12.5%)
-$4.20M(+100.0%)
Mar 1999
-
-$800.00K(-33.3%)
-$2.10M(-25.0%)
Dec 1998
-$2.80M(-34.9%)
-$1.20M(-7.7%)
-$2.80M(0.0%)
Sep 1998
-
-$1.30M(-208.3%)
-$2.80M(+3.7%)
Jun 1998
-
$1.20M(-180.0%)
-$2.70M(-46.0%)
Mar 1998
-
-$1.50M(+25.0%)
-$5.00M(+16.3%)
Dec 1997
-$4.30M(+4.9%)
-$1.20M(0.0%)
-$4.30M(+38.7%)
Sep 1997
-
-$1.20M(+9.1%)
-$3.10M(+63.2%)
Jun 1997
-
-$1.10M(+37.5%)
-$1.90M(+137.5%)
Mar 1997
-
-$800.00K
-$800.00K
Dec 1996
-$4.10M
-
-

FAQ

  • What is TG Therapeutics, Inc. annual free cash flow?
  • What is the all time high annual FCF for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual FCF year-on-year change?
  • What is TG Therapeutics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly FCF year-on-year change?
  • What is TG Therapeutics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. TTM FCF year-on-year change?

What is TG Therapeutics, Inc. annual free cash flow?

The current annual FCF of TGTX is -$40.56M

What is the all time high annual FCF for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual free cash flow is -$86.60K

What is TG Therapeutics, Inc. annual FCF year-on-year change?

Over the past year, TGTX annual free cash flow has changed by -$9.15M (-29.12%)

What is TG Therapeutics, Inc. quarterly free cash flow?

The current quarterly FCF of TGTX is -$28.74M

What is the all time high quarterly FCF for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly free cash flow is $83.70M

What is TG Therapeutics, Inc. quarterly FCF year-on-year change?

Over the past year, TGTX quarterly free cash flow has changed by -$20.53M (-250.19%)

What is TG Therapeutics, Inc. TTM free cash flow?

The current TTM FCF of TGTX is -$61.09M

What is the all time high TTM FCF for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high TTM free cash flow is $67.82M

What is TG Therapeutics, Inc. TTM FCF year-on-year change?

Over the past year, TGTX TTM free cash flow has changed by -$81.38M (-401.23%)
On this page